Cromwell Holdings LLC Raises Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Cromwell Holdings LLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,147 shares of the company’s stock after purchasing an additional 132 shares during the quarter. Cromwell Holdings LLC’s holdings in GE HealthCare Technologies were worth $108,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of GEHC. Pathway Financial Advisers LLC acquired a new stake in GE HealthCare Technologies during the 1st quarter worth approximately $25,000. BNP Paribas acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $30,000. Fred Alger Management LLC purchased a new position in GE HealthCare Technologies in the 2nd quarter valued at $26,000. Annapolis Financial Services LLC increased its stake in GE HealthCare Technologies by 171.9% in the 1st quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock valued at $32,000 after buying an additional 220 shares during the period. Finally, M&R Capital Management Inc. purchased a new position in GE HealthCare Technologies during the 3rd quarter worth $33,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $88.42 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.55. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The company has a 50-day moving average of $88.42 and a two-hundred day moving average of $83.45. The stock has a market cap of $40.36 billion, a P/E ratio of 25.85, a PEG ratio of 3.39 and a beta of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The company had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.92 earnings per share. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on GEHC. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Evercore ISI raised their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Finally, Stifel Nicolaus upped their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $94.23.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.